Greg N. Brooke

1.3k total citations
31 papers, 905 citations indexed

About

Greg N. Brooke is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Greg N. Brooke has authored 31 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Genetics. Recurrent topics in Greg N. Brooke's work include Prostate Cancer Treatment and Research (12 papers), Estrogen and related hormone effects (9 papers) and Hormonal and reproductive studies (7 papers). Greg N. Brooke is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Estrogen and related hormone effects (9 papers) and Hormonal and reproductive studies (7 papers). Greg N. Brooke collaborates with scholars based in United Kingdom, Spain and United States. Greg N. Brooke's co-authors include Charlotte L. Bevan, Filippo Prischi, Ailsa Sita-Lumsden, Jonathan Waxman, Malcolm G. Parker, D. Alwyn Dart, Sue M. Powell, R. Charles Coombes, David M. Vigushin and Christopher J. Moody and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Greg N. Brooke

30 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg N. Brooke United Kingdom 16 440 316 217 186 135 31 905
Yeong Sang Kim United States 13 614 1.4× 191 0.6× 107 0.5× 64 0.3× 55 0.4× 17 863
Amor Hajri France 19 378 0.9× 243 0.8× 138 0.6× 163 0.9× 30 0.2× 34 1.0k
Lela Buckingham United States 17 505 1.1× 175 0.6× 122 0.6× 53 0.3× 24 0.2× 48 983
Annamaria Piscazzi Italy 21 806 1.8× 131 0.4× 182 0.8× 36 0.2× 105 0.8× 40 1.3k
Shuang Cao China 19 573 1.3× 86 0.3× 289 1.3× 34 0.2× 47 0.3× 59 1.1k
Massimiliano Gaetani Sweden 19 637 1.4× 87 0.3× 45 0.2× 123 0.7× 156 1.2× 50 1.3k
Shihong Ma United States 16 334 0.8× 226 0.7× 158 0.7× 178 1.0× 41 0.3× 26 713
Leila Su United States 14 514 1.2× 83 0.3× 160 0.7× 161 0.9× 36 0.3× 19 851
Nguyen T. Van United States 15 491 1.1× 177 0.6× 67 0.3× 141 0.8× 33 0.2× 24 924
Bixin Xi China 17 488 1.1× 113 0.4× 196 0.9× 42 0.2× 33 0.2× 26 848

Countries citing papers authored by Greg N. Brooke

Since Specialization
Citations

This map shows the geographic impact of Greg N. Brooke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg N. Brooke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg N. Brooke more than expected).

Fields of papers citing papers by Greg N. Brooke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg N. Brooke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg N. Brooke. The network helps show where Greg N. Brooke may publish in the future.

Co-authorship network of co-authors of Greg N. Brooke

This figure shows the co-authorship network connecting the top 25 collaborators of Greg N. Brooke. A scholar is included among the top collaborators of Greg N. Brooke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg N. Brooke. Greg N. Brooke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jayakumar, Sundarraj, et al.. (2024). PSIP1/LEDGF reduces R-loops at transcription sites to maintain genome integrity. Nature Communications. 15(1). 361–361. 14 indexed citations
2.
Brooke, Greg N., et al.. (2024). Opportunities to advance cervical cancer prevention and care. SHILAP Revista de lepidopterología. 18. 200292–200292.
3.
Hamblin, Michael R., et al.. (2023). Generation of magnetic biohybrid microrobots based on MSC.sTRAIL for targeted stem cell delivery and treatment of cancer. Cancer Nanotechnology. 14(1). 54–54. 5 indexed citations
4.
Brooke, Greg N., et al.. (2023). A computational approach to identify efficient RNA cleaving 10–23 DNAzymes. NAR Genomics and Bioinformatics. 5(1). lqac098–lqac098. 3 indexed citations
5.
Brooke, Greg N., et al.. (2021). The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance. Oncogene. 40(22). 3775–3785. 21 indexed citations
6.
Mohr, Andrea, et al.. (2021). Fas-threshold signalling in MSCs promotes pancreatic cancer progression and metastasis. Cancer Letters. 519. 63–77. 6 indexed citations
7.
Alghamdi, Rana A., Mauro Esposito, Philip M. Mullineaux, Greg N. Brooke, & Pierre Philippe Laissue. (2021). Assessing Phototoxicity in a Mammalian Cell Line: How Low Levels of Blue Light Affect Motility in PC3 Cells. Frontiers in Cell and Developmental Biology. 9. 738786–738786. 18 indexed citations
8.
Brooke, Greg N. & Filippo Prischi. (2020). Structural and functional modelling of SARS-CoV-2 entry in animal models. Scientific Reports. 10(1). 15917–15917. 55 indexed citations
9.
Sita-Lumsden, Ailsa, et al.. (2014). Revising the role of the androgen receptor in breast cancer. Journal of Molecular Endocrinology. 52(3). R257–R265. 66 indexed citations
10.
Lavery, Derek N., Soraya Sin, Emma Spanjaard, et al.. (2014). The co‐chaperone p23 promotes prostate cancer motility and metastasis. Molecular Oncology. 9(1). 295–308. 23 indexed citations
11.
Grosdidier, Solène, Víctor Buzón, Greg N. Brooke, et al.. (2012). Allosteric Conversation in the Androgen Receptor Ligand-Binding Domain Surfaces. Molecular Endocrinology. 26(7). 1078–1090. 56 indexed citations
12.
Dart, D. Alwyn, Greg N. Brooke, Ailsa Sita-Lumsden, Jonathan Waxman, & Charlotte L. Bevan. (2011). Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens. Oncogene. 31(43). 4588–4598. 19 indexed citations
13.
Brooke, Greg N., D. Alwyn Dart, David J. Mann, et al.. (2010). FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth. Cancer Research. 71(3). 914–924. 57 indexed citations
14.
Brooke, Greg N.. (2010). But for the Grace of Genes. 24(6). 18–18. 1 indexed citations
15.
Brooke, Greg N., Malcolm G. Parker, & Charlotte L. Bevan. (2007). Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression. Oncogene. 27(21). 2941–2950. 62 indexed citations
16.
Powell, Sue M., Greg N. Brooke, Hayley C. Whitaker, et al.. (2006). Mechanisms of androgen receptor repression in prostate cancer. Biochemical Society Transactions. 34(6). 1124–1127. 15 indexed citations
17.
Gamble, Simon C., D. Alwyn Dart, Greg N. Brooke, et al.. (2006). Prohibitin, a protein downregulated by androgens, represses androgen receptor activity. Oncogene. 26(12). 1757–1768. 73 indexed citations
18.
Vigushin, David M., Greg N. Brooke, Changgang Sun, et al.. (2004). Gliotoxin Is a Dual Inhibitor of Farnesyltransferase and Geranylgeranyltransferase I with Antitumor Activity Against Breast Cancer In Vivo. Medical Oncology. 21(1). 21–30. 87 indexed citations
19.
Vigushin, David M., et al.. (2003). Pyrazino[1,2-a]indole-1,4-diones, simple analogues of gliotoxin, as selective inhibitors of geranylgeranyltransferase I. Bioorganic & Medicinal Chemistry Letters. 13(21). 3661–3663. 14 indexed citations
20.
Marson, Charles M., et al.. (2002). Cyclic acid anhydrides as a new class of potent, selective and non-peptidic inhibitors of geranylgeranyl transferase. Bioorganic & Medicinal Chemistry Letters. 12(2). 255–259. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yeong Sang Kim Breakdown of academic impact, for papers by Amor Hajri Breakdown of academic impact, for papers by Lela Buckingham Breakdown of academic impact, for papers by Annamaria Piscazzi Breakdown of academic impact, for papers by Shuang Cao Breakdown of academic impact, for papers by Massimiliano Gaetani Breakdown of academic impact, for papers by Shihong Ma Breakdown of academic impact, for papers by Leila Su Breakdown of academic impact, for papers by Nguyen T. Van Breakdown of academic impact, for papers by Bixin Xi
Rankless by CCL
2026